These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29250981)

  • 1. Update on treatment for idiopathic hypersomnia.
    Evangelista E; Lopez R; Dauvilliers Y
    Expert Opin Investig Drugs; 2018 Feb; 27(2):187-192. PubMed ID: 29250981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Medicine for Idiopathic Hypersomnia.
    Arnulf I; Leu-Semenescu S; Dodet P
    Sleep Med Clin; 2019 Sep; 14(3):333-350. PubMed ID: 31375202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review.
    Leu-Semenescu S; Louis P; Arnulf I
    Sleep Med; 2016 Jan; 17():38-44. PubMed ID: 26847972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report.
    Kelty E; Martyn V; O'Neil G; Hulse G
    J Psychopharmacol; 2014 Jul; 28(7):703-6. PubMed ID: 24554692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia.
    Saini V; Saini S
    J Clin Sleep Med; 2024 Oct; 20(10):1685-1704. PubMed ID: 38963076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review.
    Leu-Semenescu S; Nittur N; Golmard JL; Arnulf I
    Sleep Med; 2014 Jun; 15(6):681-7. PubMed ID: 24854887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study.
    Mayer G; Benes H; Young P; Bitterlich M; Rodenbeck A
    J Sleep Res; 2015 Feb; 24(1):74-81. PubMed ID: 25196321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion.
    Arnulf I; Thomas R; Roy A; Dauvilliers Y
    Sleep Med Rev; 2023 Jun; 69():101766. PubMed ID: 36921459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.
    Khan Z; Trotti LM
    Chest; 2015 Jul; 148(1):262-273. PubMed ID: 26149554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic Hypersomnia and Other Hypersomnia Syndromes.
    Trotti LM; Arnulf I
    Neurotherapeutics; 2021 Jan; 18(1):20-31. PubMed ID: 32901432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.
    Lavault S; Dauvilliers Y; Drouot X; Leu-Semenescu S; Golmard JL; Lecendreux M; Franco P; Arnulf I
    Sleep Med; 2011 Jun; 12(6):550-6. PubMed ID: 21576035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic Hypersomnia and Hypersomnolence Disorder: A Systematic Review of the Literature.
    Sowa NA
    Psychosomatics; 2016; 57(2):152-64. PubMed ID: 26895727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study.
    Inoue Y; Tabata T; Tsukimori N
    Sleep Med; 2021 Apr; 80():315-321. PubMed ID: 33631500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic hypersomnia.
    Billiard M; Sonka K
    Sleep Med Rev; 2016 Oct; 29():23-33. PubMed ID: 26599679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Sodium Oxybate in Idiopathic Hypersomnia: A Case Report Showing Improvement of Excessive Daytime Sleepiness and Reduced Symptoms.
    Vera Ricaurte M; Akhtar J; Patel P; Sundaram A; Kharel KK; Kagzi M
    Cureus; 2023 Sep; 15(9):e45976. PubMed ID: 37900508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
    Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
    Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. French consensus. Management of patients with hypersomnia: Which strategy?
    Lopez R; Arnulf I; Drouot X; Lecendreux M; Dauvilliers Y
    Rev Neurol (Paris); 2017; 173(1-2):8-18. PubMed ID: 27865546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic Hypersomnia.
    Trotti LM
    Sleep Med Clin; 2017 Sep; 12(3):331-344. PubMed ID: 28778232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.
    McClellan KJ; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):311-24. PubMed ID: 27521015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.